Why is this medication prescribed?

Durvalumab injection is typically prescribed to treat certain types of cancers, particularly advanced or metastatic forms, where the cancer has spread to other parts of the body. It belongs to a class of medications known as immune checkpoint inhibitors. Durvalumab works by helping the immune system recognize and attack cancer cells.

Durvalumab may be prescribed for the treatment of:

• Non-small cell lung cancer (NSCLC) that has not spread outside the chest, in patients whose tumors express a protein called PD-L1.
• Stage III non-small cell lung cancer (NSCLC) that cannot be surgically removed and has not progressed after treatment with chemoradiation.
• Extensive-stage small cell lung cancer (ES-SCLC), in combination with other medications.
• Bladder cancer that has spread or cannot be removed by surgery, in patients who have received chemotherapy that contains platinum and whose tumors express PD-L1.

How should this medicine be used?

Durvalumab injection is typically administered by a healthcare professional in a clinical setting, such as a hospital or an infusion center. Here’s a general overview of how Durvalumab is typically used:

• Administration: Durvalumab is given as an intravenous infusion, which means it is injected directly into a vein. The infusion is typically delivered over a specified period of time, usually ranging from 30 minutes to 60 minutes.
• Dosage: The dosage of Durvalumab can vary depending on factors such as the type of cancer being treated, the patient’s weight, overall health, and other medical considerations. Your doctor will determine the appropriate dosage for your specific condition.
• Frequency: Durvalumab is often administered every two to four weeks, depending on the treatment regimen prescribed by your doctor. Again, the frequency of administration will be determined by your healthcare provider based on your individual circumstances.
• Monitoring: During and after the infusion, your healthcare team will monitor you for any potential side effects or adverse reactions. They may also perform regular blood tests or other assessments to monitor your response to treatment.
• Duration of Treatment: The duration of treatment with Durvalumab can vary depending on factors such as the type and stage of cancer, as well as how well you respond to the medication. Your doctor will discuss the expected duration of treatment with you and may adjust the treatment plan as needed based on your progress.

It’s important to follow your doctor’s instructions carefully when receiving Durvalumab treatment. If you have any questions or concerns about your treatment plan, don’t hesitate to discuss them with your healthcare provider.

Other uses for this medicine

Durvalumab injection is primarily used for the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). However, it may also be used in clinical trials or off-label for other types of cancer or medical conditions. Off-label use refers to the use of a medication for a purpose other than its approved indication.

What special precautions should I follow?

Some special precautions to consider when using Durvalumab injection include:

• Immunotherapy-related side effects: Durvalumab works by stimulating the immune system, which can lead to immune-related side effects. These can include inflammation of various organs and tissues in the body, such as the lungs, liver, intestines, and skin. It’s essential to be aware of the signs and symptoms of these side effects and to promptly report any unusual symptoms to your healthcare provider.
• Infections: Because Durvalumab affects the immune system, it can increase the risk of infections. It’s important to practice good hygiene and take precautions to avoid exposure to infectious agents. Notify your doctor immediately if you develop signs of infection, such as fever, chills, cough, or difficulty breathing.
• Pre-existing medical conditions: Before starting treatment with Durvalumab, inform your healthcare provider about any pre-existing medical conditions you have, including autoimmune disorders, liver or kidney disease, or any other significant health issues. Your doctor may need to adjust your treatment plan or monitor you more closely if you have certain medical conditions.
• Pregnancy and breastfeeding: It’s essential to inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. The safety of Durvalumab during pregnancy and breastfeeding has not been established, and it may pose risks to the fetus or nursing infant.
• Interactions with other medications: Before starting Durvalumab treatment, make sure your doctor is aware of all other medications, supplements, and herbal remedies you are taking. Some medications may interact with Durvalumab and affect its effectiveness or increase the risk of side effects.
• Regular monitoring: Your healthcare provider will likely monitor you closely during treatment with Durvalumab to assess your response to the medication and watch for any potential side effects or complications. Be sure to attend all scheduled appointments and follow your doctor’s recommendations for follow-up care.

As always, it’s essential to discuss any questions or concerns you have about Durvalumab treatment with your healthcare provider. They can provide personalized guidance based on your individual medical history and circumstances.

What special dietary instructions should I follow?

Special dietary instructions for Durvalumab injection are generally not necessary. However, maintaining a healthy and balanced diet can support your overall health and immune function during cancer treatment. If you have specific dietary concerns or restrictions, discuss them with your healthcare provider or a registered dietitian.

What should I do if I forget a dose?

If you forget a dose of Durvalumab, contact your healthcare provider or treatment facility as soon as possible to reschedule the missed dose. It’s essential to maintain the prescribed dosing schedule to ensure the effectiveness of your treatment. Do not try to make up for a missed dose on your own or double up on doses unless instructed to do so by your healthcare provider.

What side effects can this medication cause?

Durvalumab injection, like any medication, can cause side effects. Common side effects may include:

• Fatigue: Feeling tired or weak.
• Nausea and vomiting: Feeling sick to your stomach or vomiting.
• Diarrhea: Frequent bowel movements that may be loose or watery.
• Loss of appetite: Decreased desire to eat.
• Skin rash or itching: Skin reactions such as rash or itching may occur.
• Cough: Persistent or worsening cough.
• Shortness of breath: Difficulty breathing or shortness of breath.
• Fever: Elevated body temperature.
• Muscle or joint pain: Pain or discomfort in muscles or joints.
• Headache: Pain or discomfort in the head.
• Changes in blood pressure: Increase or decrease in blood pressure.

These side effects are usually mild to moderate and may go away on their own as your body adjusts to the medication. However, if any of these side effects persist or worsen, or if you experience any other unusual symptoms, it’s important to inform your healthcare provider promptly.

In addition to these common side effects, Durvalumab injection may also cause more serious side effects in some people. These can include severe infusion reactions, immune-related side effects such as pneumonitis (inflammation of the lungs), colitis (inflammation of the colon), hepatitis (inflammation of the liver), and others. It’s important to report any unusual or severe symptoms to your healthcare provider immediately.

Your healthcare provider can provide you with more information about the potential side effects of Durvalumab injection and how to manage them effectively. They will also monitor you closely during treatment to detect and manage any side effects that may occur.

What should I know about storage and disposal of this medication?

Storage and Disposal of Durvalumab injection:

• Storage: Durvalumab injection should be stored in the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the medication in its original carton to protect it from light. Do not shake the vial.
• Disposal: Proper disposal of Durvalumab injection is important to prevent accidental exposure to others. Unused portions or empty vials should be disposed of according to local regulations for hazardous waste disposal. It’s recommended to consult your healthcare provider or pharmacist for guidance on proper disposal methods.

In case of emergency/overdose

In case of emergency or overdose, seek immediate medical attention. Symptoms of overdose may include severe side effects such as increased risk of infection, severe infusion reactions, or other adverse effects associated with Durvalumab. It’s important to inform healthcare professionals about the exact dosage and timing of the medication.

What other information should I know?

Before using Durvalumab injection, inform your healthcare provider about any allergies you have, your medical history, and all the medications you are currently taking, including prescription, over-the-counter, and herbal supplements. This medication may weaken your immune system, increasing your risk of infection, so avoid close contact with people who have infections. Report any signs of infection to your healthcare provider promptly. Regular monitoring of your condition and blood tests may be necessary during treatment with Durvalumab.

Always follow your healthcare provider’s instructions and do not change the dosage or schedule of Durvalumab injection without consulting them first. If you have any questions or concerns about the medication, don’t hesitate to discuss them with your healthcare provider or pharmacist.